Surgical septic complications of the diabetic foot – a single center experience

  • Ramona Dragomir "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
  • Ruxandra Stănculescu "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
  • Florin Bobirca Carol Davila university of Medicine and Pharmacy
  • Oana Toader "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania & “Alessandrescu – Rusescu” National Institute for Mother and Child Health, Bucharest, Romania
  • Călin Ionescu ”Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania & 5th Surgical Clinic, Cluj-Napoca Municipal Hospital, Cluj-Napoca, Romania
  • Anca Bobircă "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania & “Dr. Ion Cantacuzino” Clinical Hospital, Bucharest, Romania
Keywords: Diabetic foot, amputation, surgery, diabetes mellitus


Abstract: Diabetic foot includes all the pathogenic changes that are caused by diabetes mellitus (DM): damage to the nerves, vessels, bones and soft tissue, causing changes in the biomechanics of the foot, severe infections and tissue damage. Diabetic foot has a higher risk of amputation compared to the risk of nephropathy or retinopathy caused by DM and is the most common cause of hospitalization of patients with DM. In the management of these patients, the most important things are a good glycemic control, lifestyle change and the choice of an appropriate medical and surgical treatment. We conducted a retrospective study on 299 patients with type 1 (DMT1) or 2 (DMT2) of DM associated with septic lesions in the lower limb, hospitalized in the General Surgery Department of the Clinical Hospital „Dr. Ion Cantacuzino” between January 1, 2020-December 31, 2021. A better glycemic control was found in patients receiving insulin (20.3% ) in contrast  to those on oral antidiabetics (16.3%). Vascular involvment was found in 90.6% of cases, followed by neuropathy (27.1%). 95.5% of patients treated with insulin had arteriopathy in their disease pathology, and those treated with oral antidiabetics were diagnosed with arteriopathy in 86.7% of cases. The main type of lesion was wet gangrene, in 59.9% of patients. Necrosis and ischaemic gangrene are found in 19.7% of cases and 16.7% respectively.


1. Sapra A, Bhandari P. “Diabetes Mellitus”. [Updated 2021 Sep 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
2. Goyal, R., & Jialal, I. (2022 Jan–.). “Diabetes Mellitus Type 2”. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
3. Boulton AJM, Whitehouse RW. “The Diabetic Foot”. 2020 Mar 15. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000–.
4. Bobircă, F., Bobircă, A., Bordianu, A., Jauca, C., Georgescu, D., Radu, R., & Pătraşcu, T. ( 2018 Sept-Oct). “Current Surgical Approach in the Pathology of the Arteriopathic Predominant Diabetic Foot”. Chirurgia (Bucur), 113(5):625-633.
5. Volmer-Thole, M., & Lobmann, R. (2016 Jun 10). “Neuropathy and Diabetic Foot Syndrome”. Int J Mol Sci, 17(6):917.
6. Boulton, A., Cavanagh, P., Rayman, G., & editors. (2006). “The foot in diabetes”. 4th ed. ; Hoboken. Chichester, England: NJ: Wiley.
7. Al Wahbi A. “Operative versus non-operative treatment in diabetic dry toe gangrene”. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):959-963.
8. Beuran, M. (2013.). “Chirurgie: curs pentru studenţii din anul IV şi V. Vol. 2”. Bucureşti: Ilex.
9. Lipsky, B., Berendt, A., Deery, H., Embil, J., Joseph, W., Karchmer, A., & al., e. (2004 Oct). “Diagnosis and Treatment of Diabetic Foot Infections”. Clin Infect Dis., 39(7):885–910.
10. Bandyk DF. “The diabetic foot: Pathophysiology, evaluation, and treatment”. Semin Vasc Surg. 2018 Jun-Dec;31(2-4):43-48.
11. Alexiadou K, Doupis J. “Management of diabetic foot ulcers”. Diabetes Ther. 2012;3(1):4. doi:10.1007/s13300-012-0004-9.
12. Jacobs E, Rathmann W, Tönnies T, Arendt D, Marchowez M, Veith L, Kuss O, Brinks R, Hoyer A. “Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people”. Diabet Med. 2020 Oct;37(10):1723-1727.
13. Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative group. “Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes”. Diabetologia. 2014 Dec;57(12):2465-74. doi: 10.1007/s00125-014-3369-7. Epub 2014 Sep 17. PMID: 25226881.
14. Sanjay Kalra, Banshi Saboo. “Diabetes in special situations: Insulin in diabetic foot ulcers”. Medicinematters. 2018 Jan, Diabetic foot ulcers.
15. Edward J. Boyko, Leila R. Zelnick, Barbara H. Braffett, Rodica Pop-Busui, Catherine C. Cowie, Gayle M. Lorenzi, Rose Gubitosi-Klug, Bernard Zinman, Ian H. de Boer; for the DCCT/EDIC Research Group. “Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study”. Diabetes Care 1 February 2022; 45 (2): 357–364.